Rilmenidine ( DrugBank: Rilmenidine )


1 disease
IDDisease name (Link within this page)Number of trials
8Huntington disease1

8. Huntington disease


Clinical trials : 229 Drugs : 193 - (DrugBank : 60) / Drug target genes : 84 - Drug target pathways : 158
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2009-018119-14-GB
(EUCTR)
23/07/201018/06/2010Huntington's Disease Rilmenidine Safety Trial - Huntington's Disease Rilmenidine studyHuntington's Disease Rilmenidine Safety Trial - Huntington's Disease Rilmenidine study Huntington's Disease
MedDRA version: 14.1;Level: PT;Classification code 10070668;Term: Huntington's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders
Trade Name: Hyperium
Product Name: Rilmenidine
INN or Proposed INN: Rilmenidine
Cambridge University Hospitals NHS Foundation Trust and University of CambridgeNULLNot Recruiting Female: yes
Male: yes
16 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): noUnited Kingdom